PB1840: MONOCENTRIC EXPERIENCE OF VENETOCLAX-BASED REGIMENS FOR ACUTE MYELOID LEUKEMIA

Podobne knjige/članki

• Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience
  od: Francesco Angotzi, et al.
  Izdano: (2024-04-01)
• Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis
  od: Hongbo He, et al.
  Izdano: (2024-12-01)
• Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial
  od: Hua Jin, et al.
  Izdano: (2023-04-01)
• Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
  od: Hakan Göker, et al.
  Izdano: (2023-08-01)
• Administration of combined venetoclax and azacitidine in a patient with acute myeloid leukemia and multiple comorbidities undergoing dialysis: A case report
  od: Yuina Akagi, et al.
  Izdano: (2023-08-01)